Drug intelligence / Profile preview

Total Flavonoids of Propolis

Development stage: Phase 3
Lead developer: Green Valley Group
Modality: Small Molecules
Administration: Oral

Overview

Total Flavonoids of Propolis refers to the flavonoid-rich extract derived from propolis, a resinous substance collected by honeybees from various plants. Flavonoids are a major class of polyphenolic compounds within propolis, largely responsible for its diverse pharmacological activities. These activities include potent antioxidant, anti-inflammatory, antibacterial, antiviral, and anti-angiogenic effects. The substance is currently undergoing investigation in a Phase III clinical trial for its efficacy and safety in treating angina pectoris.

Other names: Total Flavonoids of Propolis dropping pill

Targets

AcetylcholinesteraseCOXNOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on Total Flavonoids of Propolis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Total Flavonoids of Propolis.

Explore the full profile